Data from two phase 3 studies "support the use of bimekizumab as a promising new therapeutic option for patients with ...

The tiny pills transforming the landscape: a significant shift within psoriasis treatment and the larger immunology market is ...

PRESS RELEASE - REGULATED INFIRMATION BioSenic stopped the patient recruitment for its Phase 2b ALLOB trial in mid-2023. BioSenic has prepared a global restructuring plan covering the years 2024-2032 ...

Vir Biotechnology's hepatitis D combination therapy has shown early efficacy in results from a phase 2 trial, suggesting the ...

Five-year follow-up data from the landmark CROWN trial shows significant progression-free survival in ALK+ NCSLC, but some ...

In the field of anti-CD38 treatment for multiple myeloma, Johnson & Johnson’s Darzalex casts a long shadow. Now, Sanofi hopes ...

Eastern Ohio Correction Center is entitled to summary judgment on the Title VII and state law sex discrimination claim of a terminated female deputy director who allegedly mismanaged a drug program ...

Reports of Guillain-Barré syndrome (GBS) following respiratory syncytial virus (RSV) vaccination in adults ages 60 and up ...

A contactless doorbell design based on a change in the resistance of a temperature-sensitive element when a finger approaches ...

Have you heard about the latest Ontario health-care scandal? According to the province’s opposition parties, it’s not that ...

Seyfarth Synopsis: One issue that has consistently divided the federal courts is whether an equal pay plaintiff can establish a prima faciecase of wage discrimination by pointing to a single ...

Continue to Show Benefits in Skeletal Muscle Function After 3 Years of CAP-1002 Treatment (p< 0.001)----Stabilization in Left ...